Associated Papers
Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.
Eldfors S et al.
Leukemia, 2017
27461063 (PubMed )
Supplement: leu2016202x3.xlsx › S5_Somatic_mutations
Select a paper to view details